Axel Zander active positions
| Companies | Position | Start | End |
|---|---|---|---|
SymbioCellTech LLC
 SymbioCellTech LLC BiotechnologyHealth Technology SymbioCellTech LLC engages in biotechnology company. It develops treatment to reduce or elimininate the need for external insulin therapy in insulin-dependent diabetes. The company was founded by Christof Westenfelder and Axel Zander in 2006 and is headquartered in Salt Lake, UT. | Director/Board Member | 31/12/2005 | - |
| Founder | 31/12/2005 | - | |
| Corporate Officer/Principal | 31/12/2005 | - |
Career history of Axel Zander
Former positions of Axel Zander
| Companies | Position | Start | End |
|---|---|---|---|
AlloCure, Inc.
 AlloCure, Inc. BiotechnologyHealth Technology AlloCure, Inc. develops cell therapies for the treatment of kidney diseases. It engages in developing allogeneic mesenchymal stem cell therapy for acute kidney injury. The company was founded in 2008 and is headquartered in Burlington, MA. | Chief Tech/Sci/R&D Officer | 31/12/2007 | - |
| Founder | 31/12/2007 | - |
Statistics
International
| United States | 3 |
Operational
| Founder | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Director/Board Member | 1 |
Sectoral
| Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
AlloCure, Inc.
AlloCure, Inc. BiotechnologyHealth Technology AlloCure, Inc. develops cell therapies for the treatment of kidney diseases. It engages in developing allogeneic mesenchymal stem cell therapy for acute kidney injury. The company was founded in 2008 and is headquartered in Burlington, MA. | Health Technology |
SymbioCellTech LLC
SymbioCellTech LLC BiotechnologyHealth Technology SymbioCellTech LLC engages in biotechnology company. It develops treatment to reduce or elimininate the need for external insulin therapy in insulin-dependent diabetes. The company was founded by Christof Westenfelder and Axel Zander in 2006 and is headquartered in Salt Lake, UT. | Health Technology |
- Stock Market
- Insiders
- Axel Zander
- Experience
